[Retracted] Network Pharmacology-Integrated Molecular Docking Reveals the Expected Anticancer Mechanism of Picrorhizae Rhizoma Extract

Table 4

Inhibition constant of molecular docking.

Compound	TNF	CASP3	JUN	EGFR	ESR1	HSP90AA1
Herbacetin	16.84	18.10	9.70	2.47	5.17	1.68
(5S)-5,9-Dihydroxy-4-(4-hydroxyphenyl)-5,6-dihydro-1-benzoxocin-2-one	21.6	837.08	24.82	5.82	2.87	896.3
Picroside I_qt	28.88	2.67	6.35	6.24	12.71	2.12
Hederagenin	36.22	4.12	1.28	232.7	338.48	286.36
β-Sitosterol	90.63	1.55	2.85	46.49	895.72	116.96
Scrophuloside A	158.1	11.18	503.53	-4.11	290.48	32.09
Picroside I	195.04	736.69	289.56	8.34	84.09	13.77
Picroside IV	281.61	581.03	304.36	-4.07	11.94	16.18
Scrophuloside A_QT	343.25	12.19	140.89	885.98	7.36	750.19
Picroside II_qt	442.5	15.04	48.68	41.91	590	6.66
Picroside III	455.33	42.02	139.88	-3.80	546.83	160.51
Catalpol	805.01	11.40	23.30	17.63	12.04	9.99
Catapol_qt	1.27	8.84	42.63	15.22	15.67	8.95
Picroside II	1.64	164.71	469.11	656.96	48.44	55.32
6-Feruloylcatalpol	2.19	112.86	406.18	-3.58	512.52	129.33
Aucubin	6.97	64.75	252.97	425.51	31.81	45.08